| Application no. and date | 02772624.9 (espacenet) (Federated) (European Patent Register), 20021106 | | Patent/reg. no. and date | DK/EP 1446124, 20060809 | | Publication date | 20040818 | | Priority no. and date | GB 0126879, 20011108 | | EP pub. no. and date |
EP 1446124 20040818 | | Effective date | | | Applicant/owner | AstraZeneca AB, S-151 85 Södertälje, SE | | Applicant ref. no. | | | Inventor | WEDGE, Stephen, Robert, Alderley Park
Macclesfield, Cheshire SK10 4TG, GB | | Representative | | | Opponent | | | IPC Class | A61K 31/337 (2006.01) , A61K 31/517 (2006.01) , A61K 41/00 (2006.01) , A61P 35/00 (2006.01) , A61K 31/337 (2006.01) , A61K 31/517 (2006.01) | | Title | Kombinationsterapi, der omfatter ZD6474 og et taxan | | Int. application no. | GB2002005021 | | Int. publication no. | WO2003039551 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
